The lifetime healthcare costs of female obesity: modeling of England data and the costs of current pharmacotherapy
Cardiovasc Endocrinol Metab
.
2024 Sep 20;13(4):e00310.
doi: 10.1097/XCE.0000000000000310.
eCollection 2024 Dec.
Authors
Adrian H Heald
1
2
,
Mike Stedman
3
,
John Warner-Levy
2
,
Martin B Whyte
4
,
Martin K Rutter
5
6
7
,
John Martin Gibson
1
2
Affiliations
1
The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester.
2
Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford.
3
RES Consortium, andover.
4
Department of Clinical and Experimental Medicine, University of Surrey, Guildford.
5
Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, University of Manchester, Manchester.
6
Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust.
7
Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre and.
PMID:
39318473
PMCID:
PMC11419562
DOI:
10.1097/XCE.0000000000000310
No abstract available